Journal article · 1998

Anti-Infective Strategies in Neutropenic Patients

Johan A. Maertens, M. A. Boogaerts

Acta Clinica Belgica, 53(3), 168–177 · Published 1 January 1998 · DOI 10.1080/17843286.1998.11754159

View at the publisherCite this paper

In brief

“Anti-Infective Strategies in Neutropenic Patients” is a 1998 journal article by Johan A. Maertens and M. A. Boogaerts, published in Acta Clinica Belgica. OpenAlex counts 6 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
6
Field-weighted impact
0.74
Authors
2

Abstract

In spite of considerable progress in clinical care and supportive measures, infection remains by far the principal cause of morbidity and mortality in febrile neutropenic patients, especially following intensive myelosuppressive therapy for haematological malignancies. The concept of empirical therapy, dating from the early 1970s and referring to the use of broad-spectrum antibiotics without or before… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Maertens, J. A., & Boogaerts, M. A. (1998). Anti-Infective Strategies in Neutropenic Patients. Acta Clinica Belgica, 53(3), 168–177. https://doi.org/10.1080/17843286.1998.11754159

MLA 9

Maertens, Johan A., and M. A. Boogaerts. “Anti-Infective Strategies in Neutropenic Patients.” Acta Clinica Belgica, vol. 53, no. 3, 1998, pp. 168–177. https://doi.org/10.1080/17843286.1998.11754159.

Chicago

Maertens, Johan A. and M. A. Boogaerts. 1998. “Anti-Infective Strategies in Neutropenic Patients.” Acta Clinica Belgica 53 (3): 168–177. https://doi.org/10.1080/17843286.1998.11754159.

Harvard

Maertens, J. A. and Boogaerts, M. A. (1998) ‘Anti-Infective Strategies in Neutropenic Patients’, Acta Clinica Belgica, 53(3), pp. 168–177. doi:10.1080/17843286.1998.11754159.

IEEE

J. A. Maertens and M. A. Boogaerts, “Anti-Infective Strategies in Neutropenic Patients,” Acta Clinica Belgica, vol. 53, no. 3, pp. 168–177, 1998, doi: 10.1080/17843286.1998.11754159.

BibTeX

@article{maertens1998anti,
  title     = {{Anti-Infective Strategies in Neutropenic Patients}},
  author    = {Maertens, Johan A. and Boogaerts, M. A.},
  journal   = {Acta Clinica Belgica},
  year      = {1998},
  volume    = {53},
  number    = {3},
  pages     = {168--177},
  doi       = {10.1080/17843286.1998.11754159},
  url       = {https://doi.org/10.1080/17843286.1998.11754159}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • febrile neutropenia
  • empirical antibiotic therapy
  • febrile neutropenic patients
  • hematologic malignancies
  • myelosuppressive therapy
  • gram-negative bacterial infection
  • carbapenems
  • third-generation cephalosporins

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Maertens, J. A., & Boogaerts, M. A. (1998). Anti-Infective Strategies in Neutropenic Patients. Acta Clinica Belgica, 53(3), 168–177. https://doi.org/10.1080/17843286.1998.11754159

How many times has this paper been cited?

6 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Johan A. Maertens, M. A. Boogaerts.

What is the DOI of this paper?

10.1080/17843286.1998.11754159, permanently at https://doi.org/10.1080/17843286.1998.11754159. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.